Cytochrome P450 2D6 Inhibitor Drug Class List
✉ Email this page to a colleague
Drugs in Drug Class: Cytochrome P450 2D6 Inhibitor
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Novugen | ABIRATERONE ACETATE | abiraterone acetate | TABLET;ORAL | 215947-002 | Jan 5, 2022 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Glenmark Pharms | ABIRATERONE ACETATE | abiraterone acetate | TABLET;ORAL | 209227-001 | Oct 16, 2019 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Glenmark Pharms | ABIRATERONE ACETATE | abiraterone acetate | TABLET;ORAL | 209227-002 | May 19, 2022 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |